Tepnel Pharmaceutical Services
As the best in class global provider of analytical services to the pharmaceutical sector, Tepnel Pharmaceutical Services specialises in the provision of regulatory services and analytical solutions, including cGMP drug development services, preclinical support services, clinical support services and molecular genetic services under inspection and approval of the MHRA and FDA.
Come and visit us
on Stand 49 at BioTrinity 2010, 12-14 April in Newbury, UK
, and talk to us about our Clinical/Preclinical and cGMP Development Services. For further information please contact us on +44 (0)1506 424 270 or email
pharmaservices@gen-probe.com
www.gen-probe.com
As the best in class global provider of analytical services to the pharmaceutical sector, Tepnel Pharmaceutical Services specialises in the provision of regulatory services and analytical solutions, including cGMP drug development services, preclinical support services, clinical support services and molecular genetic services under inspection and approval of the MHRA and FDA. Established for over 25 years, Tepnel Pharmaceutical Services has the experience to handle even the most complex of analytical methodologies, and is dedicated to continuously developing efficiencies on behalf of its clients. Tepnel Pharmaceutical Services is perfectly positioned to be your analytical partner of choice for all your early to late stage needs.
Tepnel Pharmaceutical Services is an established business of Gen-Probe Incorporated, a world leader in molecular diagnostics.
Product Profile:
If you need to transform your outsource experience then ask about our Pre/Clinical Support Services which consists of following;
PRECLINICAL SUPPORT SERVICESMethod development and validation
In accordance with ICH and Crystal City recommendations, Methods developed on MS, HPLC, GC, IC and immunoassays.
Sample Analysis
Independent Bioanalysis Laboratory
Sample analysis for a full range of mammalian species
Support range of preclinical investigations
GLP Toxicology Studies
ADME
Metabolism
Pharmacokinetic
Safety Pharmacology
CLINICAL SUPPORT SERVICESMethod development and validation
In accordance with ICH and Crystal City recommendations, Methods developed on MS, HPLC, GC, IC and immunoassays.
Drug Metabolism and Pharmacokinetics
Providing data in support of safety and efficacy
Phase I to Phase IV Clinical Support
API detection in biological matrices, MS, UV/VIS, IC, immunoassay
Identification and quantification of Biomarkers
Protein and genetic biomarker development
Pharmacogenomics
Illumina CSpro provider/Affymetrix service provider
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
